| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cytokinetics, Incorporated (CYTK) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. CYTK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 400.3K | $32.57M | - | |
| VP | 157.4K | $12.81M | -3,500 | |
| CFO | 100.8K | $8.21M | - | |
| Other | 87.3K | $7.10M | - | |
| VP | 58.6K | $4.76M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale+OE | 15,000 | $60.28 | $904,200.00 | -22.9% | +6.0% | - | |
| Jan 2, 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale+OE | 1,798 | $62.62 | $112,584.77 | -1.8% | +8.1% | - | |
| Dec 29, 2025 | Callos Andrew | EVP, Chief Commercial Officer | Sell | 1,809 | $62.44 | $112,953.96 | -3.4% | +2.0% | - | |
| Dec 22, 2025 | Wierenga Wendell | Director | Sale+OE | 20,000 | $66.14 | $1,322,800.00 | -38.1% | -7.1% | - | |
| Dec 16, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,200 | $61.24 | $134,728.00 | -1.6% | -1.9% | - | |
| Dec 8, 2025 | Callos Andrew | EVP, Chief Commercial Officer | Sale+OE | 1,042 | $65.96 | $68,730.32 | -2.0% | -2.7% | - | |
| Dec 5, 2025 | Callos Andrew | EVP, Chief Commercial Officer | Sale+OE | 52,486 | $65.95 | $3,461,451.70 | -50.9% | -5.3% | - | |
| Dec 2, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,200 | $63.89 | $140,558.00 | -1.5% | -3.2% | - | |
| Dec 2, 2025 | Henderson John T65 | Director | Sale+OE | 8,750 | $63.90 | $559,125.00 | -10.5% | -3.2% | - | |
| Dec 1, 2025 | Kaye Edward M. Md46 | Director | Sale+OE | 28,064 | $66.72 | $1,872,430.08 | -73.8% | -6.9% | - |